Ipratropium bromide in acute asthma exacerbation.
Flynn
C A
CA
SUNY Health Sciences Center, Syracuse, New York, USA. flynnc@mailbox.hscsyr.edu
D000208:Acute Disease; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000328:Adult; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage*; D007902:Length of Stay; D012129:Respiratory Function Tests; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D009241:Ipratropium